We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Mastercard, PayPal, Thermo Fisher, Starbucks and Simon Property
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 7, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mastercard (MA - Free Report) , PayPal (PYPL - Free Report) , Thermo Fisher (TMO - Free Report) , Starbucks (SBUX - Free Report) and Simon Property Group (SPG - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Mastercard, PayPal and Thermo Fisher
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Mastercard, PayPal and Thermo Fisher. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Buy-ranked Mastercard’s shares have increased +31.1% in the past year, significantly outperforming the Zacks Financial Transaction Services industry’s rally of +18.6%. Mastercard’s first-quarter earnings beat expectations and increased year over year.
Solid results were led by higher switched transactions, increase in cross-border volume and gross dollar volume, and gains from acquisitions, partly offset by an increase in rebates and incentives. The Zacks analyst thinks the company is poised for growth, given its solid market position, ongoing expansion and digital initiatives, and opportunities from the shift toward electronic payments. Its numerous acquisitions have aided revenue growth.
However, escalating costs will put pressure on margins. Also, in order to gain customers and new business, Mastercard has been incurring quite high levels of costs under rebates and incentives, which remains a concern. Nevertheless, its strong balance sheet enables business investment, thereby driving growth.
Shares of Buy-ranked PayPal have outperformed the Zacks Internet Software industry in the past year (+50% vs. +26%). PayPal reported mixed first quarter results with earnings surpassing expectations and falling short. However, both top-line as well as bottom line reflected year over year growth on the back of benefits from investment in MercadoLibre and increasing customer engagements on PayPal’s platform.
Further, robust Venmo and One Touch contributed well. Additionally, rapidly rising net new active accounts boosted growth in the company’s total active accounts. Growing momentum of the company’s core peer to peer also acted as a tailwind in accelerating its total payment volume.
The Zacks analyst thinks the weak eBay performance remains a headwind for the company’s total payment volume. Further, negative impacts of sale of the U.S. consumer credit receivables portfolio to Synchrony are risks to the company’s top-line growth.
Thermo Fisher’s shares have outperformed the Zacks Medical Instruments industry in the past three months (+14.7% vs. +2.6%).Thermo Fisher ended first quarter 2019 with adjusted earnings and revenues surpassing expectations. The Zacks analyst thinks the company is demonstrating strength in all end markets categorized by customer type or geography.
In the quarter, the company registered solid international performance with strong growth in Asia-Pacific including China. Also, a series of product launches aided its performance. The company’s recent purchase of Brammer Bio, operating in the field of Gene and Cell Therapy, provides cause for optimism.
This apart, the purchase of Gatan should boost electron microscopy suite. Even after considering the impact of impending divestiture of its Anatomical Pathology business, the company's 2019 guidance looks encouraging.
On the flip side, Thermo Fisher’s operating segments are getting impacted by unfavorable business mix. Competitive headwinds and escalating costs pose a threat.
Other noteworthy reports we are featuring today include Starbucks and Simon Property Group.
Will you retire a millionaire?
One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Mastercard, PayPal, Thermo Fisher, Starbucks and Simon Property
For Immediate Release
Chicago, IL – May 7, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mastercard (MA - Free Report) , PayPal (PYPL - Free Report) , Thermo Fisher (TMO - Free Report) , Starbucks (SBUX - Free Report) and Simon Property Group (SPG - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Research Reports for Mastercard, PayPal and Thermo Fisher
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Mastercard, PayPal and Thermo Fisher. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Buy-ranked Mastercard’s shares have increased +31.1% in the past year, significantly outperforming the Zacks Financial Transaction Services industry’s rally of +18.6%. Mastercard’s first-quarter earnings beat expectations and increased year over year.
Solid results were led by higher switched transactions, increase in cross-border volume and gross dollar volume, and gains from acquisitions, partly offset by an increase in rebates and incentives. The Zacks analyst thinks the company is poised for growth, given its solid market position, ongoing expansion and digital initiatives, and opportunities from the shift toward electronic payments. Its numerous acquisitions have aided revenue growth.
However, escalating costs will put pressure on margins. Also, in order to gain customers and new business, Mastercard has been incurring quite high levels of costs under rebates and incentives, which remains a concern. Nevertheless, its strong balance sheet enables business investment, thereby driving growth.
Shares of Buy-ranked PayPal have outperformed the Zacks Internet Software industry in the past year (+50% vs. +26%). PayPal reported mixed first quarter results with earnings surpassing expectations and falling short. However, both top-line as well as bottom line reflected year over year growth on the back of benefits from investment in MercadoLibre and increasing customer engagements on PayPal’s platform.
Further, robust Venmo and One Touch contributed well. Additionally, rapidly rising net new active accounts boosted growth in the company’s total active accounts. Growing momentum of the company’s core peer to peer also acted as a tailwind in accelerating its total payment volume.
The Zacks analyst thinks the weak eBay performance remains a headwind for the company’s total payment volume. Further, negative impacts of sale of the U.S. consumer credit receivables portfolio to Synchrony are risks to the company’s top-line growth.
Thermo Fisher’s shares have outperformed the Zacks Medical Instruments industry in the past three months (+14.7% vs. +2.6%).Thermo Fisher ended first quarter 2019 with adjusted earnings and revenues surpassing expectations. The Zacks analyst thinks the company is demonstrating strength in all end markets categorized by customer type or geography.
In the quarter, the company registered solid international performance with strong growth in Asia-Pacific including China. Also, a series of product launches aided its performance. The company’s recent purchase of Brammer Bio, operating in the field of Gene and Cell Therapy, provides cause for optimism.
This apart, the purchase of Gatan should boost electron microscopy suite. Even after considering the impact of impending divestiture of its Anatomical Pathology business, the company's 2019 guidance looks encouraging.
On the flip side, Thermo Fisher’s operating segments are getting impacted by unfavorable business mix. Competitive headwinds and escalating costs pose a threat.
Other noteworthy reports we are featuring today include Starbucks and Simon Property Group.
Will you retire a millionaire?
One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”
Click to get it free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.